Boehringer Increasingly Looking Outside For Oncology Growth
The private company has stressed home-grown candidates, but it's making more external plays as it builds oncology as one of the pillars of the business.
The private company has stressed home-grown candidates, but it's making more external plays as it builds oncology as one of the pillars of the business.